WCN25-1139 ANTIPLATLET AND STATIN THERAPY FOR THE PRIMARY PREVENTION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HEMODIALYSIS PATIENTS: A CASE-CONTROL STUDY
Despite the well-established benefits of antiplatelets and statins in the secondary prevention of coronary artery disease (CAD), the role of antiplatelets, and statins in hemodialysis patients, in the primary prevention of CAD is still conflicting with some studies even demonstrating a harmful effect of the treatments.
Authors
- Tanawin Suksiriworaboot
- Weerapat Kositanurit (ORCID: https://orcid.org/0000-0003-1294-7800)
- Thana Thongsricome (ORCID: https://orcid.org/0000-0002-7264-4273)
- Passawee Chevasath
Institutions
- Chulalongkorn University (TH)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1016/j.ekir.2024.11.708
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00